Sosei Heptares’ $2.6 Billion Collaboration With Neurocrine Biosciences Inc

Gowling WLG’s advised Sosei Heptares on the deal.Sosei Heptares on its collaboration with San Diego based Neurocrine Biosciences Inc to develop novel muscarinic receptor agonist compounds,…

This content is for Standard 1 Year members only.
Login Join Now
Giulia Di Palma

Author: Giulia Di Palma

This content is for Standard 1 Year members only.
Login Join Now